Подписаться
Evgeny Metelkin
Evgeny Metelkin
InSysBio, Moscow
Подтвержден адрес электронной почты в домене insysbio.com - Главная страница
Название
Процитировано
Процитировано
Год
Comprehensive study of the drug delivery properties of poly (l-lactide)-poly (ethylene glycol) nanoparticles in rats and tumor-bearing mice
V Shalgunov, D Zaytseva-Zotova, A Zintchenko, T Levada, Y Shilov, ...
Journal of Controlled Release 261, 31-42, 2017
722017
Modulation of F0F1‐ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels
C Chinopoulos, C Konràd, G Kiss, E Metelkin, B Töröcsik, SF Zhang, ...
The FEBS journal 278 (7), 1112-1125, 2011
722011
Mathematical modeling of mitochondrial adenine nucleotide translocase
E Metelkin, I Goryanin, O Demin
Biophysical Journal 90 (2), 423-432, 2006
612006
Modeling of ATP–ADP steady‐state exchange rate mediated by the adenine nucleotide translocase in isolated mitochondria
E Metelkin, O Demin, Z Kovács, C Chinopoulos
The FEBS journal 276 (23), 6942-6955, 2009
582009
DBSolve Optimum: a software package for kinetic modeling which allows dynamic visualization of simulation results
NM Gizzatkulov, II Goryanin, EA Metelkin, EA Mogilevskaya, KV Peskov, ...
BMC systems biology 4, 1-11, 2010
542010
A systems pharmacology perspective on the clinical development of fatty acid amide hydrolase inhibitors for pain
N Benson, E Metelkin, O Demin, GL Li, D Nichols, PH Van Der Graaf
CPT: pharmacometrics & systems pharmacology 3 (1), 1-7, 2014
282014
Systems pharmacology models can be used to understand complex pharmacokinetic‐pharmacodynamic behavior: an example using 5‐lipoxygenase inhibitors
O Demin, T Karelina, D Svetlichniy, E Metelkin, G Speshilov, O Demin Jr, ...
CPT: Pharmacometrics & Systems Pharmacology 2 (9), 1-9, 2013
262013
Kinetic modeling as a tool to integrate multilevel dynamic experimental data
E Mogilevskaya, N Bagrova, T Plyusnina, N Gizzatkulov, E Metelkin, ...
Protein Networks and Pathway Analysis, 197-218, 2009
242009
Confidence intervals by constrained optimization—An algorithm and software package for practical identifiability analysis in systems biology
I Borisov, E Metelkin
PLOS Computational Biology 16 (12), e1008495, 2020
162020
Kinetic modelling of the E. coli metabolism
OV Demin, TY Plyusnina, GV Lebedeva, EA Zobova, EA Metelkin, ...
Systems Biology: Definitions and Perspectives, 31-67, 2005
122005
Cellular kinetic modeling of the microbial metabolism
II Goryanin, GV Lebedeva, EA Mogilevskaya, EA Metelkin, OV Demin
Microbial Proteomics: Functional Biology of Whole Organisms, 437-488, 2006
102006
Comparison of asymptotic confidence sets for regression in small samples
D Kolobkov, O Demin, E Metelkin
Journal of Biopharmaceutical Statistics 26 (4), 742-757, 2016
42016
Kinetic Modeling of E. coli Enzymes: Integration of in vitro Experimental Data
EA Mogilevskaya, KV Peskov, EA Metelkin, GV Lebedeva, TY Plyusnina, ...
Systems Biology and Biotechnology of Escherichia coli, 177-207, 2009
32009
A kinetic model of Escherichia coli β-galactosidase
EA Metelkin, GV Lebedeva, II Goryanin, OV Demin
Biophysics 54, 156-162, 2009
22009
A kinetic model of beta-galactosidase of Escherichia coli
EA Metelkin, GV Lebedeva, II Gorianin, OV Demin
Biofizika 54 (2), 226-234, 2009
12009
PBPK MODELING FOR THERAPEUTIC NANOPARTICLES LOADED WITH DRUG: DISTRIBUTION AND RELEASE.
E Metelkin, O Demin
CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S11-S12, 2018
2018
MECHANISTIC MODELING OF CELL DYNAMICS: NEUTROPHILS SURVIVAL IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES
E Metelkin
CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S78-S79, 2017
2017
MECHANISTIC MODELING OF CELL DYNAMICS: EFFECT OF COSTIMULATORY AND CO-INHIBITORY SURFACE MOLECULES ON PROCESSES ASSOCIATED WITH CELL-TO-CELL INTERACTIONS
O Demin Jr, E Metelkin, O Demin
CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S62-S62, 2017
2017
MECHANISTIC MODEL OF NEUTROPHIL CELL DYNAMICS AND ACTIVATION TO INFORM SYSTEMS PHARMACOLOGY MODELING OF THE IMMUNE RESPONSE.
G Lebedeva, S Smirnov, E Metelkin, O Demin
CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S72-S72, 2017
2017
MECHANISTIC MODEL OF MAST CELL LIFE CYCLE, ACTIVATION AND RELEASE OF BIOACTIVE MOLECULES DESIGNED TO SUPPORT SYSTEMS PHARMACOLOGY MODELING OF THE IMMUNE RESPONSE.
G Lebedeva, S Smirnov, E Metelkin, O Demin
CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S72-S72, 2017
2017
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20